Delisting risk
Galmed Pharmaceuticals (GLMD)
Develops Aramchol candidates and CG-100 for colorectal surgery.
$4.06
Pre-market+0.02 (+0.50%)
At close$4.04(+2.93%)
Something off on this page? Send us feedback.
Next report
Nov 25, 2026
in 83 days
EPS estimate
−$3.12
Revenue estimate
—
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26Jul '26Nov '26
Reported−$2.31−$11.76−$0.62$0.63−$0.33−$0.92−$0.29Pending
Estimate——−$0.89−$0.83−$0.54−$0.38−$0.38−$3.12
Surprise——+30.3%+175.9%+38.9%−142.1%+23.7%—
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26Jul '26Nov '26
Reported—$1.6M$1.5M————Pending
Estimate——$1.5M$1.5M$1.4M———
Surprise——0.0%—————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$3.12 | — | — |
| Sep 2026 | −$3.12 | — | — |
| Aug 2026 | −$3.12 | — | — |
| Jul 2026 | −$0.38 | −$0.29 | +23.7% |
| Mar 2026 | −$0.38 | −$0.92 | −142.1% |
| Nov 2025 | −$0.54 | −$0.33 | +38.9% |
| Aug 2025 | −$0.83 | $0.63 | +175.9% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| May 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Dec 2015 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 25, 2026 | −$3.12 | — | — | — | — | — | — |
| Sep 2, 2026 | −$3.12 | — | — | — | — | — | — |
| Aug 31, 2026 | −$3.12 | — | — | — | — | — | — |
| Jul 8, 2026 | −$0.38 | −$0.29 | +23.7% | — | — | — | 0.0% |
| Mar 31, 2026 | −$0.38 | −$0.92 | −142.1% | — | — | — | +8.2% |
| Nov 26, 2025 | −$0.54 | −$0.33 | +38.9% | $1.4M | — | — | +1.8% |
| Aug 28, 2025 | −$0.83 | $0.63 | +175.9% | $1.5M | — | — | −8.0% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||||||
| May 22, 2025 | |||||||
| Apr 2, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 28, 2024 | |||||||
| May 30, 2024 | |||||||
| Apr 4, 2024 | |||||||
| Nov 22, 2023 | |||||||
| Aug 9, 2023 | |||||||
| Jun 1, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 16, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 17, 2022 | |||||||
| May 2, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 5, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 13, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Jul 31, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 23, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 16, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Nov 9, 2015 | |||||||